Clinical Trials Logo

Pain, Back clinical trials

View clinical trials related to Pain, Back.

Filter by:

NCT ID: NCT03722394 Completed - Low Back Pain Clinical Trials

Pain Neuroscience Education for Acute and Sub-Acute Low Back Pain

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

To determine if Pain Neuroscience Education (PNE) would result in positive clinical changes in patients presenting with acute or sub-acute low back pain (LBP).

NCT ID: NCT03704311 Completed - Myofascial Pain Clinical Trials

Evaluation of Mitochondrial Function in Myofascial Trigger Points Cohort Pilot Study Using High-resolution Respirometry

MitoTrigger
Start date: October 1, 2013
Phase: N/A
Study type: Interventional

This pilot study established a minimally invasive biopsy technique to obtain high-quality MTrP tissue samples to evaluate mitochondrial function via high-resolution respirometry.

NCT ID: NCT03543085 Completed - Pain, Chronic Clinical Trials

Ultra-high Frequency (500 KHz) Spinal Cord Stimulation for Treatment of Chronic Back Pain or Lower Limb Pain

Start date: April 12, 2018
Phase: N/A
Study type: Interventional

This study is a prospective, single-arm, open label, single center to confirm the effectiveness and safety of an ultra-high frequency (500 KHz) spinal cord stimulation in patients with chronic back pain or lower limb pain.

NCT ID: NCT03526055 Completed - Pain Clinical Trials

Evaluation of Conventional and Long Pulse Widths During a Temporary Spinal Cord Stimulation Trial

Start date: February 26, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of pulse widths <500 µS and >1000 µS on clinical outcomes during a temporary SCS trial.

NCT ID: NCT03429738 Completed - Pain, Acute Clinical Trials

Single-Dose Bioavailability Study of Two Formulations of Ibuprofen and Pseudoephedrine Hydrochloride Tablets

Start date: April 27, 2014
Phase: Phase 1
Study type: Interventional

Evaluation of the comparative bioavailability between two oral formulations containing ibuprofen 200 mg and pseudoephedrine 30 mg after a single dose in healthy subjects under fasting conditions.

NCT ID: NCT03421951 Terminated - Pain, Chronic Clinical Trials

Change in Pain and Quality of Life Following SCS for Chronic Pain

BURST
Start date: November 1, 2017
Phase:
Study type: Observational

Study Title Subject-reported treatment efficacy and procedure satisfaction (steps) study.BURST study- a prospective observational clinical study examining the changes in quality of life and pain following spinal cord stimulation for the treatment of chronic intractable lower back and lower limb pain.

NCT ID: NCT03350256 Completed - Pain, Intractable Clinical Trials

BurstDRā„¢ micrOdosing stimuLation in De-novo Patients

BOLD
Start date: October 30, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the therapeutic efficacy of microdosing BurstDR stimulation in spinal cord stimulation (SCS) patients with chronic intractable back and/or leg pain.

NCT ID: NCT03317275 Completed - Pain, Back Clinical Trials

Diagnostic Value of 18F-Fluoride-PET/MRI in the Management of Suspected Facet Joint Arthropathy

Start date: May 26, 2017
Phase: N/A
Study type: Interventional

Prior to the injection, the facet joints have to be defined according to standard radiological techniques (e.g. MRI and physical correlation). Patients are then sent to 18F-Fluoride-PET/MRI imaging, in order to localize facet joints with increased uptake. Facet joints to be injected are again defined according to the location(s) of highest uptake as demonstrated by 18F-Fluoride-PET/MRI. The defined injection sites before and after PET/MRI are compared. In equal defined injection sites, patients are sent for infiltration as scheduled, otherwise patients are randomized into two groups. One group will undergo facet injection(s) according to the 18F-Fluoride-PET/MRI result, with standard injections performed under CT-guidance by the radiology department of the study site. The control group will undergo facet injections blinded to the 18F-Fluoride-PET/MRI results, but based on current standard clinical practise (MRI and clinical correlation). The patients are asked to complete a validated pain and function questionnaire immediately before the facet joint injection, at 15 minutes, 1 day, 1 week and 1 month after the injection, as performed routinely in our institution. The purpose of this study is to prospectively evaluate the value of 18F-Fluoride-PET/MRI imaging in patients with low back pain with evidence of painful facet joint arthropathy, which would potentially benefit from facet joint injections.

NCT ID: NCT03110523 Withdrawn - Pain, Back Clinical Trials

A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis of the Lumbar Spine

Start date: March 30, 2023
Phase: Phase 3
Study type: Interventional

This is a Phase 3, Multicenter, Randomized, 22 Week, Double-Blind, Placebo Controlled and 3-Week, Open-Label Study to Evaluate the Efficacy and Safety of X0002 Spray in relief of the signs and symptoms of Subjects with Osteoarthritis of the Lumbar Spine. To evaluate the efficacy of X0002 spray compared to placebo for the relief of low back pain disability in subjects with osteoarthritis (OA) of the low back.